New Key Statistics Module, Z-Score and F-Score
OTCPK:BRGX Key Ratios
| Market Cap $ M | 15.21 |
| Enterprise Value $ M | 17.29 |
| P/E(ttm) | 3.18 |
| PE Ratio without NRI | 3.18 |
| Forward PE Ratio | -- |
| Price/Book | 1.59 |
| Price/Sales | -- |
| Price/Free Cash Flow | 3.18 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | 0.005 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -9.54 |
| EV-to-EBITDA | -106.74 |
| PEG | -- |
| Shares Outstanding M | 956.53 |
| Net Margin (%) | 226.35 |
| Operating Margin % | 163.42 |
| Pre-tax Margin (%) | 226.35 |
| Quick Ratio | 0.06 |
| Current Ratio | 0.11 |
| ROA % (ttm) | -16.84 |
| ROE % (ttm) | -21.20 |
| ROIC % (ttm) | -11.15 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.08 |
BRGX Number of Guru Trades
BRGX Volume of Guru Trades
Gurus Latest Trades with OTCPK:BRGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BRGX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioRegenx Inc Insider Transactions
No Available Data
News about OTCPK:BRGX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers